RxDoctor Payments Data

Eunice Ugochukwu

Psychiatric/Mental Health · Las Vegas, NVNPI 1558641092

Payments from drug & device makers

$1,172in general payments, 2019–2025

Across 65 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$247
  • Otsuka America Pharmaceutical, Inc.$202
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$190
  • Avanir Pharmaceuticals, Inc.$133
  • Sunovion Pharmaceuticals Inc.$104
  • Supernus Pharmaceuticals, Inc.$79
  • plus $219 from 6 others

What the payments were for

  • Food & beverage$1,172100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,172 in reported general payments places this provider in the 55th percentile of 362 psychiatric/mental health providers in Nevada.

See all psychiatric/mental health providers in Nevada

Medicare billing

Part B allowed, 2024
$19,886
Medicare patients
23
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$18,588
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine22$2,071
Divalproex Sodium28$1,103
Hydroxyzine Pamoate21$965
Hydroxyzine Hcl40$703
Quetiapine Fumarate44$638
Bupropion XlBupropion Hcl24$543
Aripiprazole23$542
Bupropion Hcl SrBupropion Hcl28$509
Amitriptyline Hcl22$508
Venlafaxine Hcl ErVenlafaxine Hcl20$428
Sertraline Hcl41$377
Gabapentin22$362
Olanzapine29$342
Fluoxetine Hcl57$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$202$18,58812 claims
Almatica Pharma LLCSertraline Hcl$20$37741 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 362 psychiatric/mental health providers in Nevada.

Other psychiatric/mental health in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →